FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

32704311000001108: Osimertinib 80mg tablets (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 25-May 2016. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
99829801000001110 Osimertinib 80mg tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
99829901000001116 Osimertinib 80mg tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


2 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Osimertinib 80mg tablets Has NHS dm+d (dictionary of medicines and devices) dose form indicator Discrete dose form indicator true Inferred relationship Existential restriction modifier
Osimertinib 80mg tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Osimertinib 80mg tablets Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route tablet.oral ontology form and route true Inferred relationship Existential restriction modifier
Osimertinib 80mg tablets Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Oral route true Inferred relationship Existential restriction modifier
Osimertinib 80mg tablets Is a Osimertinib true Inferred relationship Existential restriction modifier
Osimertinib 80mg tablets Plays role Antineoplastic therapeutic role true Inferred relationship Existential restriction modifier
Osimertinib 80mg tablets Is a Osimertinib false Inferred relationship Existential restriction modifier
Osimertinib 80mg tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Osimertinib 80mg tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Osimertinib 80mg tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Osimertinib 80mg tablets Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Osimertinib 80mg tablets Has active ingredient Substance with protein-tyrosine kinase inhibitor mechanism of action false Inferred relationship Existential restriction modifier
Osimertinib 80mg tablets Has specific active ingredient Osimertinib mesylate false Inferred relationship Existential restriction modifier
Osimertinib 80mg tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Osimertinib false Inferred relationship Existential restriction modifier
Osimertinib 80mg tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Osimertinib true Inferred relationship Existential restriction modifier
Osimertinib 80mg tablets Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Osimertinib 80mg tablets Has basis of strength substance Osimertinib false Inferred relationship Existential restriction modifier
Osimertinib 80mg tablets Has specific active ingredient Osimertinib mesilate true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Tagrisso 80mg tablets (Originalis B.V.) Is a True Osimertinib 80mg tablets Inferred relationship Existential restriction modifier
Tagrisso 80mg tablets (AstraZeneca UK Ltd) Is a True Osimertinib 80mg tablets Inferred relationship Existential restriction modifier
Osimertinib 80mg tablets 30 tablet Has VMP True Osimertinib 80mg tablets Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start